Ustekinumab for treating moderately to severely active CD after prior therapy

^*Corresponding author for this work

Research output: Book/Report › Commissioned report

Original language	English
Publisher	National Institute for Health and Care Excellence
Commissioning body	National Institute for Health and Care Excellence
Publication status	Published - 12 Jul 2017

Access to Document

@book{9d8e467ad62749d1ab9ddc5e54b8ecfb,

title = "Ustekinumab for treating moderately to severely active CD after prior therapy",

author = "Robert Hodgson and Mousumi Biswas and Teumzghi Mebrahtu and Walton, {Matthew James} and Melissa Harden and Woolacott, {Nerys Frances}",

year = "2017",

month = jul,

day = "12",

language = "English",

publisher = "National Institute for Health and Care Excellence",

}

TY - BOOK

T1 - Ustekinumab for treating moderately to severely active CD after prior therapy

AU - Hodgson, Robert

AU - Biswas, Mousumi

AU - Mebrahtu, Teumzghi

AU - Walton, Matthew James

AU - Harden, Melissa

AU - Woolacott, Nerys Frances

PY - 2017/7/12

Y1 - 2017/7/12

M3 - Commissioned report

BT - Ustekinumab for treating moderately to severely active CD after prior therapy

PB - National Institute for Health and Care Excellence

ER -